| Malignant Female Reproductive System Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived200 of 256show all (up to 200) |
|---|
| → investigated in trials for | Paclitaxelsmall molecule 441 trials (102 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 441 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 379 trials (82 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 379 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 266 trials (62 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 266 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 219 trials (83 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 219 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 163 trials (82 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 163 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 117 trials (26 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 117 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 108 trials (15 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 108 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 100 trials (27 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 100 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 97 trials (26 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 97 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 93 trials (40 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 93 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 66 trials (8 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 66 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Niraparibsmall molecule 62 trials (19 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 62 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 54 trials (28 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 54 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 53 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 53 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 50 trials (22 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 50 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 44 trials (17 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 44 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 39 trials (14 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 39 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 37 trials (12 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 37 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Letrozolesmall molecule 36 trials (15 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 36 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 34 trials (8 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 33 trials (4 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 33 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 33 trials (7 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 33 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 31 trials (11 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 31 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 29 trials (11 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 25 trials (7 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 24 trials (4 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ifosfamidesmall molecule 23 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 23 trials (15 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 23 trials (4 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 22 trials (5 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 22 trials (4 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 22 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fulvestrantsmall molecule 21 trials (8 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 20 trials (5 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mirvetuximab Soravtansineadc 20 trials (11 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rucaparibsmall molecule 20 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 19 trials (6 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 19 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dostarlimabmonoclonal antibody 18 trials (12 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pazopanibsmall molecule 18 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 18 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 17 trials (13 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 17 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatin/Paclitaxel Regimen 17 trials (5 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 17 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Megestrolsmall molecule 17 trials (7 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talazoparibsmall molecule 16 trials (6 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 15 trials (4 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 15 trials (5 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 14 trials (9 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 13 trials (6 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tamoxifensmall molecule 13 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 12 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall molecule 12 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 12 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adavosertibsmall molecule 11 trials (5 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 11 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bleomycin 10 trials (5 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 10 trials (6 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 10 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 10 trials (4 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trabectedinsmall molecule 10 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 10 trials (4 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall molecule 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Celecoxibsmall molecule 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 9 trials (5 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinib Mesylatesmall molecule 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pertuzumabmonoclonal antibody 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 9 trials (3 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thiotepasmall molecule 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal antibody 9 trials (7 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adjuvant Chemotherapy 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afliberceptother 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Eribulinsmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nimotuzumabmonoclonal antibody 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Relugolixsmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ribociclibsmall molecule 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sacituzumab Govitecanadc 8 trials (6 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 7 trials (4 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epirubicinsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipatasertibsmall molecule 7 trials (6 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lapatinibsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Serplulimabmonoclonal antibody 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tisotumab Vedotinadc 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anastrozolesmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aspirinsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Buparlisibsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cobimetinibsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gefitinibsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imiquimodsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitomycinsmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nintedanibsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panitumumabmonoclonal antibody 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axitinibsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capivasertibsmall molecule 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Exemestanesmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hyperthermic Intraperitoneal Chemotherapy 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leuprolideother 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Regorafenibsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Therapeutic Tumor Infiltrating Lymphocytes 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumab Emtansineadc 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adebrelimabmonoclonal antibody 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alemtuzumabmonoclonal antibody 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alpelisibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Arsenic Trioxidesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Catumaxomabmonoclonal antibody 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dordavipronesmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzalutamidesmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fruquintinibsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lifileucelcell therapy 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lurbinectedinsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitoxantronesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ridaforolimussmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selumetinibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avutometinib And Defactinib 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Berzosertibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Binimetinibsmall molecule 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dactinomycinother 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elacestrantsmall molecule 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elimusertibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzastaurinsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFOX Regimen 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ganetespibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Guadecitabinesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxychloroquinesmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunotherapy 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Inavolisibsmall molecule 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Iniparibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Neratinibsmall molecule 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prexasertibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Retifanlimabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tanespimycinsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tivozanibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Valproic Acidsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zoledronic Acidsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvocidibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bendamustinesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Busulfansmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabazitaxelsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camizestrantsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Conatumumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Datopotamab Deruxtecanadc 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Denosumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Disitamab Vedotinadc 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Entrectinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erdafitinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFIRI Regimen 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Futibatinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Goserelinother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imlunestrantsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lucitanibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mercaptopurinesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nilotinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Osimertinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemigatinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Perifosinesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pilaralisibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Quisinostatsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ramucirumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Samotolisibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Seribantumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sonidegibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Taxol 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tretinoinsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Uprosertibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vandetanibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinblastinesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vistusertibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zanidatamabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abexinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abirateronesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Acalabrutinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Agerafenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alectinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvespimycinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aminolevulinic Acidsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anti-VEGF Monoclonal Antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Female Reproductive System Neoplasm | 1 | Observed | clinicaltrials | graph → |